Core Laboratories Statistics
Share Statistics
Core Laboratories has 46.7M
shares outstanding. The number of shares has increased by -0.16%
in one year.
| Shares Outstanding | 46.7M |
| Shares Change (YoY) | -0.16% |
| Shares Change (QoQ) | -0.26% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 50 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 6.61M, so 14.12% of the outstanding
shares have been sold short.
| Short Interest | 6.61M |
| Short % of Shares Out | 14.12% |
| Short % of Float | 27.4% |
| Short Ratio (days to cover) | 9.92 |
Valuation Ratios
The PE ratio is 25.85 and the forward
PE ratio is 11.18.
Core Laboratories's PEG ratio is
-1.7.
| PE Ratio | 25.85 |
| Forward PE | 11.18 |
| PS Ratio | 1.55 |
| Forward PS | 0.8 |
| PB Ratio | 3.22 |
| P/FCF Ratio | 18.72 |
| PEG Ratio | -1.7 |
Financial Ratio HistoryEnterprise Valuation
Core Laboratories has an Enterprise Value (EV) of 972.77M.
| EV / Sales | 1.86 |
| EV / EBITDA | 13.28 |
| EV / EBIT | 17.25 |
| EV / FCF | 22.43 |
Financial Position
The company has a current ratio of 2.32,
with a Debt / Equity ratio of 0.71.
| Current Ratio | 2.32 |
| Quick Ratio | 1.71 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 2.46 |
| Debt / FCF | 4.15 |
| Interest Coverage | 4.73 |
Financial Efficiency
Return on Equity is 12.46% and Return on Invested Capital is 8.08%.
| Return on Equity | 12.46% |
| Return on Assets | 5.32% |
| Return on Invested Capital | 8.08% |
| Revenue Per Employee | $154,072.94 |
| Profits Per Employee | $9,235.29 |
| Employee Count | 3,400 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 7.33 |
Taxes
| Income Tax | 14.03M |
| Effective Tax Rate | 30.54% |
Stock Price Statistics
The stock price has increased by -35.17% in the
last 52 weeks. The beta is 1.45, so Core Laboratories's
price volatility has been higher than the market average.
| Beta | 1.45 |
| 52-Week Price Change | -35.17% |
| 50-Day Moving Average | 13.43 |
| 200-Day Moving Average | 17.64 |
| Relative Strength Index (RSI) | 37.73 |
| Average Volume (20 Days) | 463,955 |
Income Statement
In the last 12 months, Core Laboratories had revenue of 523.85M
and earned 31.4M
in profits. Earnings per share was 0.67.
| Revenue | 523.85M |
| Gross Profit | 88.37M |
| Operating Income | 58.56M |
| Net Income | 31.4M |
| EBITDA | 73.27M |
| EBIT | 58.56M |
| Earnings Per Share (EPS) | 0.67 |
Full Income StatementBalance Sheet
The company has 19.16M in cash and 180.14M in
debt, giving a net cash position of -160.99M.
| Cash & Cash Equivalents | 19.16M |
| Total Debt | 180.14M |
| Net Cash | -160.99M |
| Retained Earnings | n/a |
| Total Assets | 591.52M |
| Working Capital | 125.04M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 56.39M
and capital expenditures -13.03M, giving a free cash flow of 43.36M.
| Operating Cash Flow | 56.39M |
| Capital Expenditures | -13.03M |
| Free Cash Flow | 43.36M |
| FCF Per Share | 0.92 |
Full Cash Flow StatementMargins
Gross margin is 16.87%, with operating and profit margins of 11.18% and 5.99%.
| Gross Margin | 16.87% |
| Operating Margin | 11.18% |
| Pretax Margin | 8.77% |
| Profit Margin | 5.99% |
| EBITDA Margin | 13.99% |
| EBIT Margin | 11.18% |
| FCF Margin | 8.28% |
Dividends & Yields
CLB pays an annual dividend of $0.05,
which amounts to a dividend yield of 0.33%.
| Dividend Per Share | $0.05 |
| Dividend Yield | 0.33% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 8.47% |
| Earnings Yield | 3.87% |
| FCF Yield | 5.34% |
Dividend DetailsAnalyst Forecast
The average price target for CLB is $15.5,
which is 39.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $15.5 |
| Price Target Difference | 39.9% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
Stock ForecastsStock Splits
The last stock split was on Jul 9, 2010. It was a
forward
split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.48 |
| Piotroski F-Score | 8 |
